On January 5, 2023, RaQualia Pharma Inc. closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
638 JPY | +2.90% |
|
+6.33% | -7.27% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.27% | 84.99M | |
+63.05% | 856B | |
+39.25% | 631B | |
-4.78% | 359B | |
+17.52% | 325B | |
+8.43% | 297B | |
+13.58% | 244B | |
+4.95% | 234B | |
+16.20% | 226B | |
+14.63% | 177B |
- Stock Market
- Equities
- 4579 Stock
- News RaQualia Pharma Inc.
- RaQualia Pharma Inc. announced that it has received ¥805.6125 million in funding from CVI Investments, Inc.